Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma - case series and literature review.
Szudy-Szczyrek A, Chocholska S, Bachanek-Mitura O, Czabak O, Mlak R, Szczyrek M, Muzyka-Kasietczuk J, Hus M. Szudy-Szczyrek A, et al. Among authors: hus m. Ann Agric Environ Med. 2022 Mar 21;29(1):103-109. doi: 10.26444/aaem/137788. Epub 2021 Jun 15. Ann Agric Environ Med. 2022. PMID: 35352912 Free article. Review.
Thalidomide treatment of resistant or relapsed multiple myeloma patients.
Hus M, Dmoszynska A, Soroka-Wojtaszko M, Jawniak D, Legiec W, Ciepnuch H, Hellmann A, Wolska-Smolen T, Skotnicki A, Manko J; Polish Multiple Myeloma Study Group. Hus M, et al. Haematologica. 2001 Apr;86(4):404-8. Haematologica. 2001. PMID: 11325647 Clinical Trial.
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.
Hus M, Grzasko N, Szostek M, Pluta A, Helbig G, Woszczyk D, Adamczyk-Cioch M, Jawniak D, Legiec W, Morawska M, Kozinska J, Waciński P, Dmoszynska A. Hus M, et al. Ann Hematol. 2011 Oct;90(10):1161-6. doi: 10.1007/s00277-011-1276-2. Epub 2011 Jun 23. Ann Hematol. 2011. PMID: 21698395 Free PMC article. Clinical Trial.
1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens.
Grzasko N, Hus M, Chocholska S, Pluta A, Hajek R, Dmoszynska A. Grzasko N, et al. Among authors: hus m. Leuk Lymphoma. 2012 Dec;53(12):2500-3. doi: 10.3109/10428194.2012.684349. Epub 2012 May 22. Leuk Lymphoma. 2012. PMID: 22497640 No abstract available.
133 results